157 related articles for article (PubMed ID: 36863914)
1. Pathogenesis of histologic variations of appendiceal mucinous neoplasms.
Sugarbaker PH; Chang D; Liang J
Eur J Surg Oncol; 2023 May; 49(5):895-901. PubMed ID: 36863914
[TBL] [Abstract][Full Text] [Related]
2. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
3. Total abdominal colectomy to facilitate complete cytoreduction in 56 patients with mucinous appendiceal neoplasms with peritoneal metastases.
Sugarbaker PH; Chang D
J Surg Oncol; 2023 May; 127(6):1011-1018. PubMed ID: 36785941
[TBL] [Abstract][Full Text] [Related]
4. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
5. Palliation of mucinous appendiceal neoplasms with peritoneal metastases with total abdominal colectomy.
Sugarbaker PH; Chang D
J Surg Oncol; 2023 May; 127(6):1019-1027. PubMed ID: 36825427
[TBL] [Abstract][Full Text] [Related]
6. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.
Reghunathan M; Kelly KJ; Valasek MA; Lowy AM; Baumgartner JM
Ann Surg Oncol; 2018 Mar; 25(3):702-708. PubMed ID: 29282599
[TBL] [Abstract][Full Text] [Related]
7. Lymph node positive pseudomyxoma peritonei.
Sugarbaker PH; Chang D
Eur J Surg Oncol; 2022 Dec; 48(12):2369-2377. PubMed ID: 35941031
[TBL] [Abstract][Full Text] [Related]
8. Secondary cytoreductive surgery for 86 patients with mucinous appendiceal adenocarcinoma.
Sugarbaker PH; Chang D
J Surg Oncol; 2023 May; 127(6):999-1010. PubMed ID: 36734844
[TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
[TBL] [Abstract][Full Text] [Related]
11. Incomplete cytoreduction with peritoneal metastases from appendiceal mucinous neoplasms.
Sugarbaker PH; Chang D
J Surg Oncol; 2022 Dec; 126(8):1462-1470. PubMed ID: 36102369
[TBL] [Abstract][Full Text] [Related]
12. Similar Survival Among All Subtypes of Mucinous Appendiceal Adenocarcinoma Except the Intermediate Subtype, Which Shows an Improved Survival.
Sugarbaker PH; Chang D; Liang JJ
Ann Surg Oncol; 2023 Mar; 30(3):1874-1885. PubMed ID: 36542246
[TBL] [Abstract][Full Text] [Related]
13. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
Huang Y; Alzahrani NA; Chua TC; Morris DL
Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
[TBL] [Abstract][Full Text] [Related]
14. The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Milovanov V; Sardi A; Studeman K; Nieroda C; Sittig M; Gushchin V
Ann Surg Oncol; 2016 Jun; 23(6):1928-33. PubMed ID: 26714951
[TBL] [Abstract][Full Text] [Related]
15. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.
Misdraji J; Yantiss RK; Graeme-Cook FM; Balis UJ; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1089-103. PubMed ID: 12883241
[TBL] [Abstract][Full Text] [Related]
16. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
17. Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm.
Mercado M; Shamavonian R; Cheng E; Ahmadi N; Morris DL
Anticancer Res; 2023 Feb; 43(2):817-822. PubMed ID: 36697077
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Garach NR; Kusamura S; Guaglio M; Bartolini V; Deraco M; Baratti D
Eur J Surg Oncol; 2021 May; 47(5):1132-1139. PubMed ID: 33280949
[TBL] [Abstract][Full Text] [Related]
19. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy.
Sutton PA; O'Dwyer ST; Barriuso J; Aziz O; Selvasekar CR; Renehan AG; Wilson MS
Surg Oncol; 2021 Sep; 38():101572. PubMed ID: 33915487
[TBL] [Abstract][Full Text] [Related]
20. Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients.
Sugarbaker PH; Chang D
J Surg Oncol; 2024 May; ():. PubMed ID: 38752445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
